home_office

UK Home office reclassifies Epidyolex as a Schedule 5 drug

June 24, 2020
Research and Development CBD, cannabiodiol, cannabis

The Home Office has announced that the drug Epidyolex (cannabidiol) has been reclassified as a Schedule 5 drug, a move …

shutterstock_138095450

Boehringer withdraws its £700m investment in Hikma Pharmaceuticals

June 23, 2020
Manufacturing and Production, Sales and Marketing Boehringer, Hikma

Boehringer has revealed that it intends to withdraw its investment from Hikma Pharmaceuticals, with the company poised to sell 28 …

saney

MHRA extends Santhera’s Puldysa on the Early Access to Medicines Scheme

June 23, 2020
Manufacturing and Production

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has extended Santhera’s Duchenne muscular dystrophy (DMD) drug Puldysa (idebone) for …

vaccinesss_1

Sanofi expects approval for its COVID-19 vaccine by the start of 2021

June 23, 2020
Manufacturing and Production COVID-19, coronavirus

Sanofi has said it expects to have its coronavirus vaccine approved by the start of next year which is faster …

gilead-sciences

Gilead to investigate inhaled formulation of promising COVID-19 therapy remdesivir

June 23, 2020
Manufacturing and Production, Research and Development COVID-19, Gilead, remdesivir

Gilead is intent on pushing the applications of its antiviral drug remdesivir after it has shown efficacy in the treatment …

fda

FDA and EMA agree to intensify collaboration during COVID-19 pandemic

June 23, 2020
Manufacturing and Production COVID-19, coronavirus

Senior officials from the US Food and Drug Administration and the European Medicines Agency have pledged to continue working closely …

pexels-photo-3044623_araruna

How is COVID-19 impacting the rare disease community?

June 22, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, cambridge rare disease network, pharma, rare disease

The COVID-19 pandemic has altered the life of just about everyone, especially patients in receiving continued treatment and care. But …

sanofi

Sanofi’s Dupixent scores Chinese approval in moderate to severe atopic dermatitis

June 22, 2020
Sales and Marketing China, Dupixent, Sanofi, atopic dermatitis, pharma

China’s National Medical Products Administration (NMPA) has moved to approve a 300mg pre-filled pen formulation of Sanofi and Regeneron’s Dupixent …

800px-mantoux_tuberculin_skin_test_greg_knobloch

New UK consortium established to monitor COVID-19 vaccine efficacy once they hit market

June 22, 2020
Manufacturing and Production, Sales and Marketing COVID-19, DSRU, MEMO Research, Vaccine, coronavirus, pharma

The UK’s Drug Safety Research Unit (DSRU) and the University of Dundee’s Medicines Monitoring Unit (MEMO Research) have come together …

lockdown_uk

SAGE group warns it is not safe to relax social distancing rules across Britain

June 22, 2020
Sales and Marketing COVID-19, coronavirus, pandemic

The Independent SAGE group has warned that it is not safe to relax social distancing rules for indoor settings, after …

nih_clinical_research_center_aerial

NIH halts hydroxychloroquine trial after no benefit found in COVID-19 patients

June 22, 2020
Sales and Marketing COVID-19, chloroquine, hydroxychloroquine, pandemic

The National Institutes of Health (NIH) have suspended clinical trials of hydroxychloroquine after the drug was found to have no …

sidewalk

Germany’s infection rate rapidly rises as world sees its largest daily increase in COVID-19 cases

June 22, 2020
Sales and Marketing COVID-19, coronavirus, pandemic

Germany’s coronavirus R number has drastically increased while the world faced its largest increase in cases since the pandemic began. …

shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020
Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …

mozzie

Florida approve plan to release 750 million genetically modified mosquitoes to stop the spread of disease

June 19, 2020
Medical Communications AIDS, HIV, mosquitoes

Florida state regulators have gained approval to release 750 million genetically modified mosquitoes across the state to reduce the spread …

fda

FDA approves Crysvita for treating tumour-induced osteomalacia

June 19, 2020
Medical Communications FDA, FDA approvals

The FDA has approved Crysvita (burosumabtwza) injection to treat patients over two years old with tumour-induced osteomalacia (TIO). This is …

top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

June 19, 2020
Medical Communications COVID-19, coronavirus, top 10

The news this week centres around COVID-19 vaccines, as Moderna is to start testing 30,000 people with its vaccine beginning …

asthma

Study launched to assess if asthma treatment ciclesonide can treat COVID-19

June 18, 2020
Business Services COVID-19, asthma, corona, coronavirus

Researchers at the University of Buffalo have launched a study to see if the steroid treatment ciclesonide could be effective …

contact_me

Experts warn UK government that unnecessary deaths will occur if lockdown is lifted before contact tracing system is implemented

June 18, 2020
Business Services COVID, COVID-19, coronavirus

The British government is risking many unnecessary deaths if it lifts the lockdown before an effective contact tracing system is …

The Gateway to Local Adoption Series

Latest content